Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 44 citing Salvarani: Infliximab plus prednisone or placebo plus prednisone for the initial treatment.... (0.10 sec) 

Polymyalgia rheumatica and giant-cell arteritis

- nejm.org
C Salvarani, F Cantini, GG Hunder - The Lancet, 2008 - Elsevier
Polymyalgia rheumatica and giant-cell arteritis are closely related disorders
that affect people of middle age and older. They frequently occur together. Both
are syndromes of unknown cause, but genetic and environmental factors might ...
Cited by 390 - Related articles - BL Direct - All 28 versions

Updated consensus statement on biological agents for the treatment of rheumatic diseases, …


DE Furst, FC Breedveld, JR Kalden, JS … - British Medical Journal, 2007 - ard.bmj.com
As in previous years, the consensus group to consider the use of biological
agents was constituted by rheumatologists from the universities of Erlangen,
Leiden and Vienna in Europe in cooperation with other universities in the ...
Cited by 78 - Related articles - BL Direct - All 5 versions

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a …

- annals.org [PDF] 
GS Hoffman, MC Cid, KE Rendt-Zagar, PA … - Annals of Internal Medicine, 2007 - Am Coll Physicians
Gary S. Hoffman, MD; Maria C. Cid, MD; Karen E. Rendt-Zagar, MD; Peter A.
Merkel, MD, MPH; Cornelia M. Weyand, MD; John H. Stone, MD, MPH; Carlo
Salvarani, MD; Weichun Xu, PhD; Sudha Visvanathan, PhD; and Mahboob U. ...
Cited by 66 - Related articles - BL Direct - All 3 versions

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and …


VM Martinez-Taboada, V Rodriguez-Valverde, … - British Medical Journal, 2008 - ard.bmj.com
Results: Baseline characteristics were similar in the two groups, although
patients in the etanercept group showed higher levels of basal glycaemia (p =
0.02) and a higher erythrocyte sedimentation rate (ESR) (p = 0.01). After ...
Cited by 12 - Related articles - BL Direct - All 3 versions

Treatment of refractory polymyalgia rheumatica with etanercept: An open pilot study


MG Catanoso, P Macchioni, L Boiardi, N … - Arthritis Rheum, 2007 - interscience.wiley.com
The study group comprised patients with relapsing PMR who were not able to
reduce their prednisone dosage below 7.5-10 mg/day and who had experienced
corticosteroid-related side effects. Patients received injections of ...
Cited by 11 - Related articles - BL Direct - All 3 versions

Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis


GS Hoffman, MC Cid, KE Rendt-Zagar, PA … - Annals of Internal Medicine, 2007 - Am Coll Physicians
Gary S. Hoffman, MD; Maria C. Cid, MD; Karen E. Rendt-Zagar, MD; Peter A.
Merkel, MD, MPH; Cornelia M. Weyand, MD; John H. Stone, MD, MPH; Carlo
Salvarani, MD; Weichun Xu, PhD; Sudha Visvanathan, PhD; and Mahboob U. ...
Cited by 8

A systematic review of the off-label use of biological therapies in systemic autoimmune …


M Ramos-Casals, P Brito-Zerón, S Muñoz, MJ … - Medicine, 2008 - journals.lww.com
Abstract: In 2006, the Study Group on Autoimmune Diseases (GEAS) of the Spanish
Society of Internal Medicine created the BIOGEAS project, a multicenter study
devoted to collecting data on the use of biological agents in adult ...
Cited by 7 - Related articles - All 3 versions

Improving therapeutic options for patients with giant cell arteritis


N Pipitone, C Salvarani - Current opinion in rheumatology, 2008 - journals.lww.com
Recent findings: An initial dose of 40-60 mg/day of prednisone is usually
adequate. Patients at risk of developing ischemic complications require dosages
of around 1 mg/kg/day, whereas pulse glucocorticoid therapy is no more ...
Cited by 7 - Related articles - BL Direct - All 7 versions

Giant cell arteritis: an updated review


A Kawasaki, V Purvin, HOJ Gonin - Acta Ophthalmol, 2009 - interscience.wiley.com
Giant cell arteritis (GCA) is the most common primary vasculitis of adults. The
incidence of this disease is practically nil in the population under the age of
50 years, then rises dramatically with each passing decade. The median age ...
Cited by 4 - Related articles - All 2 versions

Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and …


VM Martinez-Taboada, L Alvarez, M RuizSoto … - Cytokine, 2008 - Elsevier
Results: PMR and GCA are characterized by a hyperproduction of IL-6. The role of
other circulating cytokines in their pathogenesis remains unclear. Cytokine mRNA
in the arterial wall of GCA can distinguish different clinical subgroups of ...
Cited by 3 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google